These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6108392)

  • 1. Hepatitis B vaccine: immune responses in haemodialysis patients.
    Stevens CE; Szmuness W; Goodman AI; Weseley SA; Fotino M
    Lancet; 1980 Dec; 2(8206):1211-3. PubMed ID: 6108392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B vaccine.
    Lancet; 1980 Dec; 2(8206):1229-30. PubMed ID: 6108398
    [No Abstract]   [Full Text] [Related]  

  • 3. Simultaneous passive and active immunization against hepatitis B: noninterference of hepatitis B immune globulin with the anti-HBs response to reduced doses of heat-inactivated hepatitis B vaccine.
    Lelie PN; Reesink HW; Grijm R; de Jong-van Manen ST; Reerink-Brongers EE
    Hepatology; 1986; 6(5):971-5. PubMed ID: 3758947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of hepatitis B surface antibody and immune memory to hepatitis B vaccine among medical college students in Madinah.
    Mahallawi W
    Ann Saudi Med; 2018; 38(6):413-419. PubMed ID: 30531175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients.
    Crosnier J; Jungers P; Couroucé AM; Laplanche A; Benhamou E; Degos F; Lacour B; Prunet P; Cerisier Y; Guesry P
    Lancet; 1981 Apr; 1(8224):797-800. PubMed ID: 6111671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
    Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
    Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B in haemodialysis: vaccination against HBS antigen.
    Crosnier J
    Proc Eur Dial Transplant Assoc; 1981; 18():231-40. PubMed ID: 7036150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to two different hepatitis B vaccines in haemodialysis patients: a 2-year follow-up.
    de Graeff PA; Dankert J; de Zeeuw D; Gips CH; van der Hem GK
    Nephron; 1985; 40(2):155-60. PubMed ID: 4000344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study.
    Wong VC; Ip HM; Reesink HW; Lelie PN; Reerink-Brongers EE; Yeung CY; Ma HK
    Lancet; 1984 Apr; 1(8383):921-6. PubMed ID: 6143868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active hepatitis B immunization with an experimental German vaccine. I. Immunogenicity studies in healthy adults. II. The primary 19 S and 7 S responses to HBsAg in healthy adults. III. Immunogenicity studies in hemodialysis patients.
    Scheiermann N; Kuwert EK
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):439-55. PubMed ID: 6485639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response in neonates to hepatitis B vaccine.
    Barin F; Goudeau A; Denis F; Yvonnet B; Chiron JP; Coursaget P; Mar ID
    Lancet; 1982 Jan; 1(8266):251-3. PubMed ID: 6120276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
    Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
    Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of vaccination with the hepatitis B vaccine in patients and personnel at the Hemodialysis Center in Karlovac].
    Palmović D; Vitas B; Doko A; Belavić Z; Racki L
    Lijec Vjesn; 1989 Nov; 111(11):400-4. PubMed ID: 2534601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of three booster doses hepatitis B vaccine on the persistence of immune-protection among infants with normal and high antibody response to primary vaccination: a matched case-control study].
    Feng Y; Lyu J; Liu J; Yan B; Song L; Liang X; Li L; Zhang G; Wang F; Zhang L; Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Apr; 37(4):460-3. PubMed ID: 27087206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to a recombinant hepatitis B vaccine in hemodialysis patients.
    Docci D; Cipolloni PA; Baldrati L; Capponcini C; Turci F; Feletti C
    Int J Artif Organs; 1990 Jul; 13(7):451-3. PubMed ID: 2144846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.
    Zanetti AR; Romanò L; Giambi C; Pavan A; Carnelli V; Baitelli G; Malchiodi G; Valerio E; Barale A; Marchisio MA; Montù D; Tozzi AE; D'Ancona F;
    Lancet Infect Dis; 2010 Nov; 10(11):755-61. PubMed ID: 20884297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term evaluation of the hepatitis B vaccine (Heptavax-B) in hemodialysis patients.
    Pasko MT; Bartholomew WR; Beam TR; Amsterdam D; Cunningham EE
    Am J Kidney Dis; 1988 Apr; 11(4):326-31. PubMed ID: 2965511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to a heat-inactivated hepatitis B vaccine in patients undergoing hemodialysis. Enhancement of the response by increasing the dose of hepatitis B surface antigen from 3 to 27 micrograms.
    Lelie PN; Reesink HW; de Jong-van Manen ST; Dees PJ; Reerink-Brongers EE
    Arch Intern Med; 1985 Feb; 145(2):305-9. PubMed ID: 3977491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vaccination against hepatitis B in a hemodialysis unit. A 4-year follow up (author's transl)].
    Pengloan J; Bagros P; Jourdan JL; Nivet H; Goudeau A; Dubois F; Barin F
    Nephrologie; 1982; 3(1):32-5. PubMed ID: 7088262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.